|
TCRX Tscan Therapeutics Inc 1783328 |
| Balance Sheet |
|
Current Assets
|
$132,766,000.00 |
|
Assets
|
$201,991,000.00 |
|
Current Liabilities
|
$19,970,000.00 |
|
Liabilities
|
$105,069,000.00 |
|
Equity
|
$96,922,000.00 |
|
Shares Out
|
61074000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-24,279,000.00 |
|
Investing Cash Flow
|
$-70,000.00 |
| Market Analysis |
Market Cap
|
$46,416,240.00 |
|
Price
|
$0.74 |
|
PB
|
7.33 |
|
EPS
|
-0.22 |
|
PS
|
16.48 |
|
FCF
|
$-24,349,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:40 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:38 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.28 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TCRX documents filed with the SEC.
TCRX Filings
Clear
